Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that Dr. Mark Pykett, Navidea Chief Executive Officer, will participate at BioCentury’s NewsMakers in the Biotech Industry Conference on September 27, 2013 at the Millennium Broadway Hotel and Conference Center in New York City, NY. Dr. Pykett will provide an update of the Company and its development programs including initial data from its Manocept™ platform at 10:00 AM EDT.
Help employers find you! Check out all the jobs and post your resume.
